Tuesday, 15 October 2019

Generics News

  • Daiichi Sankyo's subsidiary launches four new generic drugs

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Jun, 2015

    Daiichi Sankyo Company Limited has announced that on Friday, June 19, its generics subsidiary, Daiichi Sankyo Espha, will launch seven new generic drugs with four new active ingredients. T...Read more

  • US FDA extends timeline for generic drug approval

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: In a recent move, the US Food and Drug Administration (FDA) has decided to extend the timeline for granting tentative approval to generic drug applications. The timelines of appl...Read more

  • FDA approves generic versions of Plavix

    Generics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 18 May, 2012

    Singapore: The US Food and Drug Administration has approved generic versions of the blood thinning drug Plavix (clopidogrel bisulfate), which helps reduce the risk of heart attack and strok...Read more

  • FDA finds hair from human arm in Ranbaxy drugs

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

    Singapore: The US FDA released a set of further current good manufacturing practices (cGMP) violations that have been noticed at leading Indian drug maker Ranbaxy's Mohali unit. As per the ...Read more

  • TWi Pharma launches generic version of appetite loss drug

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 29 Jul, 2015

    Singapore: Taiwan based TWi Pharmaceuticals, has launched generic version of Par Pharmaceutical's Megace ES (megestrol acetate oral suspension) 625mg/5ml after the United States District Co...Read more

  • Trans-Pacific trade talks reach stalemate over IP rights

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: What started as an effort to lower trade barriers across 12 Pacific Rim nations, from the US and Canada to Vietnam and Chile, the Trans Pacific Partnership negotiations has broug...Read more

  • Activists challenge Gilead to give up Hep C drug patent

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 May, 2015

    Singapore: Initiative for Medicines, Access & Knowledge (I-MAK), a team of lawyers and scientists campaigning for global accessibility of medicines for hepatitis C and HIV patients, has...Read more

  • Teva, Sun to pay $2.15 bn to Pfizer, Takeda to settle patent suit

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jun, 2013

    Singapore: Teva Pharmaceuticals Industries, Israel, and Sun Pharmaceutical Industries, India, are going to pay a combined amount of $2.15 billion to US-based Pfizer in order to settle a pat...Read more

  • Daiichi Sankyo collaborates with Maruishi Pharmaceutical

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jun, 2015

    Japan's Daiichi Sankyo Company and Maruishi Pharmaceutical Co. Ltd have signed an agreement to collaborate on the commercialization of the general anaesthesia analgesic, generic Remifentani...Read more

  • Teva to uphold Copaxone patent until May 2015

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: Israel-based Teva Pharmaceuticals has recieved favourable response in England and Wales regarding the validity of the asserted claims of UK patent 762,888 relating to Copaxone (g...Read more

  • Pricing revision to cost Indian pharma $160 mn

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 25 Jun, 2013

    Mumbai: The pharmaceutical industry will be widely impacted after India's National Pharmaceutical Pricing Authority (NPPA) notified leading drug majors about ceiling prices. This will lead ...Read more

  • US antidepressant market slides down by 4%: report

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 14 Oct, 2013

    Singapore: Antidepressant market in US, that peaked at USD12 billion in 2008, has lost USD2.6 billion due to expired patents in the following years and currently stands at USD9.4 billion, d...Read more

  • Australia's Starpharma develops Zika-proof condoms for athletes ahead of Rio Olympics

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2016

    Australia's Starpharma Holdings Ltd and Ansell Limited have announced that the Australian Olympic team will be provided with antiviral Dual Protect VivaGel condoms for the upcoming Olympic ...Read more

  • Celgene settles litigation with India's Natco

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2015

    Singapore: US based Celgene has settled the litigation with India's Natco Pharma, Natco's US partner, Arrow International and Arrow's parent company, Watson Laboratories relating to patents...Read more

  • Self monitoring diabetes market to reach $358 mn

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 23 Jul, 2013

    Singapore: Three quarters of the population of China and India are diabetic. This translates to a patient pool of nearly 200 million for the self monitoring of blood glucose (SMBG) market. ...Read more

  • Do India's bad quality drugs end up in Africa?

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2014

    Singapore: According to a research conducted by the National Bureau of Economic Research, some generic drugs sent from India to Africa are of lower quality, when compared to the same medici...Read more

  • Will Japan be able to reduce its generic drug prices?

    Generics |  Analysis | By BioSpectrum Bureau  | 0 Comment | 21 May, 2013

    The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the US. Although it records annual sales of approximately $64.5 billion (...Read more

  • Daiichi Sankyo to commercialize AstraZeneca's nasal influenza vaccine in Japan

    Generics |  News | By BioSpectrum Bureau  | 0 Comment | 02 Sep, 2015

    The global biologics research and development arm of AstraZeneca, MedImmune LLC, has entered into an exclusive license agreement with Daiichi Sankyo Company Ltd. to develop and commercializ...Read more



Survey Box

Is Asia-Pacific dominating the global digital transformation in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls